U.S. Markets close in 6 hrs 4 mins

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
135.54-0.01 (-0.01%)
As of 9:55AM EDT. Market open.
People also watch
NBIXINCYVICLALKSMDCO

Ligand Pharmaceuticals Incorporated

3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121
United States
858-550-7500
http://www.ligand.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees22

Key Executives

NameTitlePayExercisedAge
Mr. John L. HigginsChief Exec. Officer and Exec. Director967.36k469.5k47
Mr. Matthew W. FoehrPres and Chief Operating Officer697.43k2.6M44
Mr. Matthew KorenbergChief Financial Officer, Principal Accounting Officer and VP of Fin.505.12kN/A42
Mr. Charles S. Berkman J.D.VP, Gen. Counsel and Sec.471.86k2.08M48
Ms. Audrey Warfield-GrahamVP of HRN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; CorMatrix portfolio of vascular, cardiac, and pericardial tissue repair products; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Carnexiv that is used as replacement therapy for oral carbamazepine formulations; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. The company’s partners programs, which are in clinical development used for the treatment of seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, kidney disease, and others. Its internal development program comprise products for the treatment of Type 2 diabetes mellitus, oncology, allergy, anti-coagulant, depression, sun damage, blood disorders, and diabetes. The company is also involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated has alliances, licenses, and other business relationships with various pharmaceutical companies, including Novartis AG; Amgen, Inc.; Merck & Co., Inc.; Pfizer Inc.; Celgene; Gilead Sciences; Janssen Biotech, Inc.; Baxter International, Inc.; and Eli Lilly and Company. The company was founded in 1987 and is headquartered in San Diego, California.

Corporate Governance

Ligand Pharmaceuticals Incorporated’s ISS Governance QualityScore as of September 1, 2017 is 8. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.